chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Breast tenderness, Burning sensation, Nodule, Pruritus
Clinical narrative: Burning sensation; Itching; Lump in the armpit; Tenderness in left breast; Throbbing pain in left breast; Affected areas feel hot to touch; Swelling near injection site; Redness near injection site; Circle near injection site has gotten larger; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BURNING SENSATION (Burning sensation), PRURITUS (Itching), NODULE (Lump in the armpit), BREAST TENDERNESS (Tenderness in left breast) and BREAST PAIN (Throbbing pain in left breast) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Burning sensation), PRURITUS (Itching), NODULE (Lump in the armpit), BREAST TENDERNESS (Tenderness in left breast), BREAST PAIN (Throbbing pain in left breast), VACCINATION SITE WARMTH (Affected areas feel hot to touch), VACCINATION SITE SWELLING (Swelling near injection site), VACCINATION SITE ERYTHEMA (Redness near injection site) and VACCINATION SITE RASH (Circle near injection site has gotten larger). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) on 22-Mar-2021 at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Burning sensation), PRURITUS (Itching), NODULE (Lump in the armpit), BREAST TENDERNESS (Tenderness in left breast), BREAST PAIN (Throbbing pain in left breast), VACCINATION SITE WARMTH (Affected areas feel hot to touch), VACCINATION SITE SWELLING (Swelling near injection site), VACCINATION SITE ERYTHEMA (Redness near injection site) and VACCINATION SITE RASH (Circle near injection site has gotten larger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. On 22 Mar 2021,the patient went to HCP(health care professional).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Burning sensation; Itching; Lump in the armpit; Tenderness in left breast; Throbbing pain in left breast; Affected areas feel hot to touch; Swelling near injection site; Redness near injection site; Circle near injection site has gotten larger; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BURNING SENSATION (Burning sensation), PRURITUS (Itching), NODULE (Lump in the armpit), BREAST TENDERNESS (Tenderness in left breast) and BREAST PAIN (Throbbing pain in left breast) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Burning sensation), PRURITUS (Itching), NODULE (Lump in the armpit), BREAST TENDERNESS (Tenderness in left breast), BREAST PAIN (Throbbing pain in left breast), VACCINATION SITE WARMTH (Affected areas feel hot to touch), VACCINATION SITE SWELLING (Swelling near injection site), VACCINATION SITE ERYTHEMA (Redness near injection site) and VACCINATION SITE RASH (Circle near injection site has gotten larger). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) on 22-Mar-2021 at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Burning sensation), PRURITUS (Itching), NODULE (Lump in the armpit), BREAST TENDERNESS (Tenderness in left breast), BREAST PAIN (Throbbing pain in left breast), VACCINATION SITE WARMTH (Affected areas feel hot to touch), VACCINATION SITE SWELLING (Swelling near injection site), VACCINATION SITE ERYTHEMA (Redness near injection site) and VACCINATION SITE RASH (Circle near injection site has gotten larger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. On 22 Mar 2021,the patient went to HCP(health care professional).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site pain
Clinical narrative: experiencing sore muscles in neck where she can barely turn her head; Some soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (experiencing sore muscles in neck where she can barely turn her head) and VACCINATION SITE PAIN (Some soreness at injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M201A) for COVID-19 vaccination.     The patient's past medical history included Neck pain (She had a history of stiff/painful neck tenderness).    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced NECK PAIN (experiencing sore muscles in neck where she can barely turn her head) and VACCINATION SITE PAIN (Some soreness at injection site). At the time of the report, NECK PAIN (experiencing sore muscles in neck where she can barely turn her head) and VACCINATION SITE PAIN (Some soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Pain in extremity, Presyncope, Tinnitus
Clinical narrative: Had a sore arm a couple of days; Like he was going to pass out; Felt lightheaded; Sweating; His ear was ringing for 10 minutes; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Like he was going to pass out), DIZZINESS (Felt lightheaded), HYPERHIDROSIS (Sweating), TINNITUS (His ear was ringing for 10 minutes) and PAIN IN EXTREMITY (Had a sore arm a couple of days) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PRESYNCOPE (Like he was going to pass out), DIZZINESS (Felt lightheaded), HYPERHIDROSIS (Sweating) and TINNITUS (His ear was ringing for 10 minutes). On an unknown date, the patient experienced PAIN IN EXTREMITY (Had a sore arm a couple of days). On 26-Feb-2021, PRESYNCOPE (Like he was going to pass out), DIZZINESS (Felt lightheaded), HYPERHIDROSIS (Sweating) and TINNITUS (His ear was ringing for 10 minutes) had resolved. At the time of the report, PAIN IN EXTREMITY (Had a sore arm a couple of days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment.  No relevant concomitant medications were reported. Treatment information was not provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 10-Apr-2021. On 11-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 11-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drug was received by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up received on included no new information.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Bone pain, Chills, Fatigue
Clinical narrative: Arm hurt; Back was hurting worse than it ever did; Sensations going through her body; Had strange feelings in her body; Bones ached; She was so nervous; Joint pain; Chills; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), BACK PAIN (Back was hurting worse than it ever did), PARAESTHESIA (Sensations going through her body), FEELING ABNORMAL (Had strange feelings in her body) and BONE PAIN (Bones ached) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included FUROSEMIDE, METOPROLOL and RIVAROXABAN (XARELTO) for an unknown indication.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt), BACK PAIN (Back was hurting worse than it ever did), PARAESTHESIA (Sensations going through her body), FEELING ABNORMAL (Had strange feelings in her body), BONE PAIN (Bones ached), NERVOUSNESS (She was so nervous), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Felt tired). The patient was treated with ALPRAZOLAM for Anxiety, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm hurt), BACK PAIN (Back was hurting worse than it ever did), PARAESTHESIA (Sensations going through her body), FEELING ABNORMAL (Had strange feelings in her body), BONE PAIN (Bones ached), NERVOUSNESS (She was so nervous), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Felt tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nervousness, Pain in extremity, Paraesthesia
Clinical narrative: Arm hurt; Back was hurting worse than it ever did; Sensations going through her body; Had strange feelings in her body; Bones ached; She was so nervous; Joint pain; Chills; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), BACK PAIN (Back was hurting worse than it ever did), PARAESTHESIA (Sensations going through her body), FEELING ABNORMAL (Had strange feelings in her body) and BONE PAIN (Bones ached) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety. Concomitant products included FUROSEMIDE, METOPROLOL and RIVAROXABAN (XARELTO) for an unknown indication.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt), BACK PAIN (Back was hurting worse than it ever did), PARAESTHESIA (Sensations going through her body), FEELING ABNORMAL (Had strange feelings in her body), BONE PAIN (Bones ached), NERVOUSNESS (She was so nervous), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Felt tired). The patient was treated with ALPRAZOLAM for Anxiety, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm hurt), BACK PAIN (Back was hurting worse than it ever did), PARAESTHESIA (Sensations going through her body), FEELING ABNORMAL (Had strange feelings in her body), BONE PAIN (Bones ached), NERVOUSNESS (She was so nervous), ARTHRALGIA (Joint pain), CHILLS (Chills) and FATIGUE (Felt tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Wrong vaccine administeredI´m not sure if both shots were Moderna...I think 1 was Pfizer; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong vaccine administeredI´m not sure if both shots were Moderna...I think 1 was Pfizer) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong vaccine administeredI´m not sure if both shots were Moderna...I think 1 was Pfizer). At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong vaccine administeredI´m not sure if both shots were Moderna..I think 1 was Pfizer) outcome was unknown.            no concomitant drugs included no treatment drugs included
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Urticaria, Vaccination site pain
Clinical narrative: Erythema; Hives; Swelling arm; Itch; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Erythema), PRURITUS (Itch), URTICARIA (Hives), PERIPHERAL SWELLING (Swelling arm) and VACCINATION SITE PAIN (Vaccination site pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 21-Mar-2021, the patient experienced PRURITUS (Itch). On 22-Mar-2021, the patient experienced ERYTHEMA (Erythema), URTICARIA (Hives) and PERIPHERAL SWELLING (Swelling arm). The patient was treated with DIPHENHYDRAMINE at a dose of 1 dosage form. At the time of the report, ERYTHEMA (Erythema), PRURITUS (Itch), URTICARIA (Hives), PERIPHERAL SWELLING (Swelling arm) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were high blood pressure medication.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy exposure to ultraviolet light, Induration, Injection site swelling, Swelling, Tenderness
Clinical narrative: A little tender, 2 or 3 square inch area; Hardness; There is swollen; Her arm at the injection site is red; She was exposed to the sun straight for about 35 minutes; There were little bumps; At the arm in the injection site it began to itch; A sore arm very local to the area of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (A sore arm very local to the area of the injection site). On 22-Mar-2021, the patient experienced HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) and INJECTION SITE SWELLING (There were little bumps). On 23-Mar-2021, the patient experienced TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE ERYTHEMA (Her arm at the injection site is red). On 19-Mar-2021, VACCINATION SITE PAIN (A sore arm very local to the area of the injection site) had resolved. On 22-Mar-2021, HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) and INJECTION SITE SWELLING (There were little bumps) had resolved. At the time of the report, TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE ERYTHEMA (Her arm at the injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included anti itch cream (1% cortisone). Caladryl  (Pramoxine-calamine).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received contains no new information.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: A little tender, 2 or 3 square inch area; Hardness; There is swollen; Her arm at the injection site is red; She was exposed to the sun straight for about 35 minutes; There were little bumps; At the arm in the injection site it began to itch; A sore arm very local to the area of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (A sore arm very local to the area of the injection site). On 22-Mar-2021, the patient experienced HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) and INJECTION SITE SWELLING (There were little bumps). On 23-Mar-2021, the patient experienced TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE ERYTHEMA (Her arm at the injection site is red). On 19-Mar-2021, VACCINATION SITE PAIN (A sore arm very local to the area of the injection site) had resolved. On 22-Mar-2021, HEAVY EXPOSURE TO ULTRAVIOLET LIGHT (She was exposed to the sun straight for about 35 minutes), VACCINATION SITE PRURITUS (At the arm in the injection site it began to itch) and INJECTION SITE SWELLING (There were little bumps) had resolved. At the time of the report, TENDERNESS (A little tender, 2 or 3 square inch area), INDURATION (Hardness), SWELLING (There is swollen) and VACCINATION SITE ERYTHEMA (Her arm at the injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included anti itch cream (1% cortisone). Caladryl  (Pramoxine-calamine).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received contains no new information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dysgeusia, Paraesthesia oral, Rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (bad taste after the first dose), ASTHENIA (wave of weakness), DIZZINESS (lightheaded), PARAESTHESIA ORAL (tingling in the tongue) and RASH (rash on the feet) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced DYSGEUSIA (bad taste after the first dose). On 02-Mar-2021, the patient experienced ASTHENIA (wave of weakness), DIZZINESS (lightheaded) and PARAESTHESIA ORAL (tingling in the tongue). On an unknown date, the patient experienced RASH (rash on the feet). The patient was treated with PREDNISONE at an unspecified dose and frequency. On 02-Feb-2021, DYSGEUSIA (bad taste after the first dose) had resolved. On 02-Mar-2021, ASTHENIA (wave of weakness), DIZZINESS (lightheaded) and PARAESTHESIA ORAL (tingling in the tongue) had resolved. At the time of the report, RASH (rash on the feet) outcome was unknown. Not Provided          Patient was taking antihistamine per doctor recommendation. No concomitant medication details was reported.
Sex: U
Vaccine: COVID19
Symptoms: Axillary pain, Headache, Limb discomfort, Pain in extremity
Clinical narrative: Headache; Two hours after vaccine, pain from shoulder to hand; Couldnt move her arm due to pain, four hours after vaccine; Pain is moving to her armpit and her left side of back; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Two hours after vaccine, pain from shoulder to hand), LIMB DISCOMFORT (Couldnt move her arm due to pain, four hours after vaccine), AXILLARY PAIN (Pain is moving to her armpit and her left side of back) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Two hours after vaccine, pain from shoulder to hand), LIMB DISCOMFORT (Couldnt move her arm due to pain, four hours after vaccine) and AXILLARY PAIN (Pain is moving to her armpit and her left side of back). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Two hours after vaccine, pain from shoulder to hand), LIMB DISCOMFORT (Couldnt move her arm due to pain, four hours after vaccine), AXILLARY PAIN (Pain is moving to her armpit and her left side of back) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment information was not provided.   Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: patient got the first dose of the Moderna vaccine on 27Jan2021 and still has not received the; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (patient got the first dose of the Moderna vaccine on 27Jan2021 and still has not received the) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Chronic pain (Oxycodone for chronic pain.). Concomitant products included OXYCODONE for Chronic pain, LISINOPRIL for Hypertension.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (patient got the first dose of the Moderna vaccine on 27Jan2021 and still has not received the). At the time of the report, PRODUCT DOSE OMISSION ISSUE (patient got the first dose of the Moderna vaccine on 27Jan2021 and still has not received the) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema, Vaccination site vesicles, Vaccination site warmth
Clinical narrative: has a bull's eye at the site of injection; warm; has a darker red circle to the border; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE VESICLES (has a bull's eye at the site of injection), VACCINATION SITE WARMTH (warm), PAIN (soreness) and VACCINATION SITE ERYTHEMA (has a darker red circle to the border) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced PAIN (soreness). On 23-Mar-2021, the patient experienced VACCINATION SITE VESICLES (has a bull's eye at the site of injection), VACCINATION SITE WARMTH (warm) and VACCINATION SITE ERYTHEMA (has a darker red circle to the border). On 15-Mar-2021, PAIN (soreness) had resolved. At the time of the report, VACCINATION SITE VESICLES (has a bull's eye at the site of injection), VACCINATION SITE WARMTH (warm) and VACCINATION SITE ERYTHEMA (has a darker red circle to the border) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use were reported as Birth control pills. No treatment information was reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Mar-2021: Significant Follow up Appended
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate increased, Peripheral swelling
Clinical narrative: Swollen feet; fast heart beat; rush in her risk to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen feet), HEART RATE INCREASED (fast heart beat) and FEELING ABNORMAL (rush in her risk to her elbow) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen feet), HEART RATE INCREASED (fast heart beat) and FEELING ABNORMAL (rush in her risk to her elbow). At the time of the report, PERIPHERAL SWELLING (Swollen feet), HEART RATE INCREASED (fast heart beat) and FEELING ABNORMAL (rush in her risk to her elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: size of the palm of your hand; hot to touch; itching at injection site; left arm swelling at vaccination site; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (size of the palm of your hand), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE SWELLING (left arm swelling at vaccination site) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Asymptomatic COVID-19 in 2021. Concurrent medical conditions included Sulfonamide allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), PARACETAMOL (TYLENOL), GABAPENTIN and OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ADVERSE EVENT (size of the palm of your hand), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE SWELLING (left arm swelling at vaccination site) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, ADVERSE EVENT (size of the palm of your hand), VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (itching at injection site), VACCINATION SITE SWELLING (left arm swelling at vaccination site) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included blood pressure medication and antibiotic.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: information regarding second dose updated NNI FOR DOSE ONE
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: 1st dose of the Moderna vaccine and by day number 39 she has not received the 2nd dose yet.; Really Sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine and by day number 39 she has not received the 2nd dose yet.) and PAIN IN EXTREMITY (Really Sore arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029AOL) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medial history reported). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine and by day number 39 she has not received the 2nd dose yet.) and PAIN IN EXTREMITY (Really Sore arm). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose of the Moderna vaccine and by day number 39 she has not received the 2nd dose yet.) outcome was unknown and PAIN IN EXTREMITY (Really Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Medication regularly taken: Blood pressure medication, Lipitor, fluid pill, thyroid medication. No Treatment information provided
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: itching; sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (itching) and PAIN IN EXTREMITY (sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 13-Mar-2021, the patient experienced PRURITUS (itching) and PAIN IN EXTREMITY (sore arm). At the time of the report, PRURITUS (itching) and PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitant medications and treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-017475 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-017475:crosslink
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of diarrhea in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Mar 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 17, 2021, patient experienced diarrhea. At the time of the report, diarrhea outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use, treatment information and lab details not provided. Patient stated she went to her doctor and after a test, he determined the diarrhea was caused by antibiotics she had taken after oral surgery. Most recent follow-up information incorporated above includes: On May 11, 2021: Reporter comment added.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Gait inability, Pain in extremity
Clinical narrative: pain in his foot; it's hard to walk and bend himself; he's lame; he started having chills for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in his foot), GAIT INABILITY (it's hard to walk and bend himself), GAIT INABILITY (he's lame) and CHILLS (he started having chills for 3 days) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in his foot), GAIT INABILITY (it's hard to walk and bend himself), GAIT INABILITY (he's lame) and CHILLS (he started having chills for 3 days). The patient was treated with IBUPROFEN (ADVEL) for Prophylaxis, at an unspecified dose and frequency. On 20-Mar-2021, CHILLS (he started having chills for 3 days) had resolved. At the time of the report, PAIN IN EXTREMITY (pain in his foot), GAIT INABILITY (it's hard to walk and bend himself) and GAIT INABILITY (he's lame) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included advel.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Myalgia, Pyrexia
Clinical narrative: diarrhea; began having fever; chills; body aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (began having fever), CHILLS (chills) and MYALGIA (body aches) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PYREXIA (began having fever), CHILLS (chills) and MYALGIA (body aches). On 22-Mar-2021, the patient experienced DIARRHOEA (diarrhea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DIARRHOEA (diarrhea), PYREXIA (began having fever), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: aches/pain/soreness; low-grade fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches/pain/soreness), PYREXIA (low-grade fever) and CHILLS (chills) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included POTASSIUM for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (aches/pain/soreness), PYREXIA (low-grade fever) and CHILLS (chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (aches/pain/soreness), PYREXIA (low-grade fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication including high blood pressure pill and sugar pill.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Headache, Myalgia
Clinical narrative: diarrhea; a little weakness; muscle pain; headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (a little weakness), MYALGIA (muscle pain) and HEADACHE (headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (a little weakness), MYALGIA (muscle pain) and HEADACHE (headache). At the time of the report, DIARRHOEA (diarrhea), ASTHENIA (a little weakness), MYALGIA (muscle pain) and HEADACHE (headache) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: NNI, FU call with patient's granddaughter, granddaughter states patient has no email and no one to speak on patient's behalf
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Twinging; pain is in her shoulder and left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Twinging) and PAIN (pain is in her shoulder and left side) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B121A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, High cholesterol and Overweight.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Twinging) and PAIN (pain is in her shoulder and left side). At the time of the report, PAIN (Twinging) and PAIN (pain is in her shoulder and left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported.  Treatment medication not reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Rash on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash on the injection site). At the time of the report, VACCINATION SITE RASH (Rash on the injection site) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information provided as none.   Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fall, Headache, Hot flush, Joint injury
Clinical narrative: getting hot flashes; Aches in lower back/pain in lower back; Pain in back of legs; headache everyday; Had a fall; Hurt elbow; Pounding in ears; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (getting hot flashes), BACK PAIN (Aches in lower back/pain in lower back), TINNITUS (Pounding in ears), PAIN IN EXTREMITY (Pain in back of legs) and FALL (Had a fall) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M0A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bronchitis (January 2021). Concurrent medical conditions included Arthritis and Diabetes (2020). Concomitant products included GLIMEPIRIDE and METFORMIN for Diabetes, VITAMIN B12 NOS, MULTIVITAMIN FOR WOMEN and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced FALL (Had a fall) and JOINT INJURY (Hurt elbow). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HOT FLUSH (getting hot flashes), BACK PAIN (Aches in lower back/pain in lower back), TINNITUS (Pounding in ears), PAIN IN EXTREMITY (Pain in back of legs) and HEADACHE (headache everyday). The patient was treated with ACETAMINOPHEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (getting hot flashes) and BACK PAIN (Aches in lower back/pain in lower back) had not resolved, TINNITUS (Pounding in ears) and HEADACHE (headache everyday) had resolved and PAIN IN EXTREMITY (Pain in back of legs), FALL (Had a fall) and JOINT INJURY (Hurt elbow) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: follow up was received on 18 may 2021 patient demographics, date of the events, other events ,events outcome, concomitant medication was updated.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tinnitus
Clinical narrative: getting hot flashes; Aches in lower back/pain in lower back; Pain in back of legs; headache everyday; Had a fall; Hurt elbow; Pounding in ears; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (getting hot flashes), BACK PAIN (Aches in lower back/pain in lower back), TINNITUS (Pounding in ears), PAIN IN EXTREMITY (Pain in back of legs) and FALL (Had a fall) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M0A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bronchitis (January 2021). Concurrent medical conditions included Arthritis and Diabetes (2020). Concomitant products included GLIMEPIRIDE and METFORMIN for Diabetes, VITAMIN B12 NOS, MULTIVITAMIN FOR WOMEN and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced FALL (Had a fall) and JOINT INJURY (Hurt elbow). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HOT FLUSH (getting hot flashes), BACK PAIN (Aches in lower back/pain in lower back), TINNITUS (Pounding in ears), PAIN IN EXTREMITY (Pain in back of legs) and HEADACHE (headache everyday). The patient was treated with ACETAMINOPHEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, HOT FLUSH (getting hot flashes) and BACK PAIN (Aches in lower back/pain in lower back) had not resolved, TINNITUS (Pounding in ears) and HEADACHE (headache everyday) had resolved and PAIN IN EXTREMITY (Pain in back of legs), FALL (Had a fall) and JOINT INJURY (Hurt elbow) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: follow up was received on 18 may 2021 patient demographics, date of the events, other events ,events outcome, concomitant medication was updated.